Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 133, doi. 10.1038/sj.cgt.7700758
- By:
- Publication type:
- Article
Works matching IS 09291903 AND DT 2005 AND VI 12 AND IP 2
Results: 10
1
2
Replication-selective oncolytic viruses in the treatment of cancer.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 141, doi. 10.1038/sj.cgt.7700771
- By:
- Publication type:
- Article
3
Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 109, doi. 10.1038/sj.cgt.7700773
- By:
- Publication type:
- Article
4
Employment of microarray analysis to characterize biologic differences associated with tropism-modified adenoviral vectors: utilization of non-native cellular entry pathways.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 162, doi. 10.1038/sj.cgt.7700776
- By:
- Publication type:
- Article
5
Intratumoral administration of immature dendritic cells following the adenovirus vector encoding CD40 ligand elicits significant regression of established myeloma.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 122, doi. 10.1038/sj.cgt.7700757
- By:
- Publication type:
- Article
6
Vascular administration of adenoviral vector soaked in absorbable gelatin sponge particles (GSP) prolongs the transgene expression in hepatocytes.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 116, doi. 10.1038/sj.cgt.7700744
- By:
- Publication type:
- Article
7
Systemic administration of attenuated Salmonella choleraesuis carrying thrombospondin-1 gene leads to tumor-specific transgene expression, delayed tumor growth and prolonged survival in the murine melanoma model.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 175, doi. 10.1038/sj.cgt.7700777
- By:
- Publication type:
- Article
8
Depletion of CD25<sup>+</sup> cells from human T-cell enriched fraction eliminates immunodominance during priming with dendritic cells genetically modified to express a secreted protein.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 185, doi. 10.1038/sj.cgt.7700778
- By:
- Publication type:
- Article
9
Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 198, doi. 10.1038/sj.cgt.7700781
- By:
- Publication type:
- Article
10
Suppression of peritoneal implantation of gastric cancer cells by adenovirus vector-mediated NK4 expression.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 2, p. 206, doi. 10.1038/sj.cgt.7700782
- By:
- Publication type:
- Article